Remarkable response to nivolumab in sarcomatoid malignant pleural mesothelioma with high PD‐L1

We report herein a case of sarcomatoid malignant pleural mesothelioma (MPM) with high PD‐L1 expression who was refractory to standard chemotherapy but had a remarkable and sustained response to nivolumab. A 78‐year‐old man presented with right chest pain. Computed tomography (CT) showed a solid mass...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsubouchi, Kazuya, Inoue, Shigesato, Ibusuki, Ritsu, Iwasaki, Takeshi, Harada, Taishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020311/
https://www.ncbi.nlm.nih.gov/pubmed/32148838
http://dx.doi.org/10.1002/rcr2.536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020311/
https://www.ncbi.nlm.nih.gov/pubmed/32148838
http://dx.doi.org/10.1002/rcr2.536

Ejemplares similares